Latest

neuropsychopharmacology

Featured Psychology

·January 29, 2018·3 min read

New Insight into SSRI Antidepressants

A new study could lead to the development of additional SSRIs to help treat depression and anxiety.

Featured Neuroscience Open Neuroscience Articles Psychology

·January 26, 2018·5 min read

Magic Mushrooms May Alter How You Feel About Nature (and Politics)

Months after receiving psilocybin treatments for depression, patients report feeling more connected with nature and experience a shift away from authoritarian political views, researchers report.

Featured Neuroscience Open Neuroscience Articles Psychology

·January 15, 2018·8 min read

Can Psychedelic Drugs ‘Reconnect’ Depressed Patients with Their Emotions?

Two new studies consider the potential of using psychedelics to help treat depression. Imperial College London researchers report psilocybin, the active compound in magic mushrooms, can help to relieve symptoms of depression without the dulling of emotions associated with SSRIs. The researchers note the psychedelic experience could help to maintain long term mental health for those with treatment resistant depression.

Image shows a girl holding her head in her hands.

Featured Psychology

·January 3, 2018·5 min read

ADHD Increases STI Risk, But Medications May Help Reduce It

A new study reveals ADHD increases the risk of sexually transmitted infections in adolescents threefold compared to the general population. However, the use of ADHD medications reduces the risk of STIs in males by up to 41%.

Featured Neurology Open Neuroscience Articles

·December 20, 2017·5 min read

Antidepressant May Help Combat the Course of Multiple Sclerosis

A new Nature Communications study reports the antidepressant Clomipramine may relieve symptoms of primary progressive multiple sclerosis.

Featured Neuroscience Psychology

·December 18, 2017·5 min read

New Vaccine Technology Shows Promise as a Tool to Combat the Opioid Crisis

A new vaccine blocks the effects of heroin by preventing the drug from crossing the blood-brain barrier. Researchers believe the vaccine could be helpful in curbing the opioid epidemic.

Featured Psychology

·November 17, 2017·3 min read

New Therapy Lessens Impact of Early Age Mistreatment

For male victims of childhood mistreatment, specific medications can prevent or reduce epigentic marks and improve behavior, a new study reports. However, this does not appear to be the case for females. Researchers note that the study underlies the importance of recognizing sex differences in research and treatments.

Featured Genetics Psychology

·November 8, 2017·2 min read

Gene Breakthrough on Lithium Treatment for Bipolar Disorder

University of Adelaide researchers report schizophrenia linked genes in bipolar patients may explain why some don't respond to lithium.

Featured Open Neuroscience Articles Psychology

·October 13, 2017·6 min read

Magic Mushrooms May ‘Reset’ Brains of Depressed Patients

A new study adds to growing evidence supporting the benefits of psychedelics to treat mental illnesses. Researchers report psilocybin, the psychoactive compound in magic mushrooms, is effective in reducing symptoms for people with treatment resistant depression. The study reveals the compound resets the activity of a brain network associated with depression, helping to improve symptoms in patients for up to 5 weeks following treatment.

Featured Neurology Neuroscience Videos

·October 6, 2017·2 min read

Researchers Studying Drug’s Potential to Prevent Alzheimer’s

Researchers are testing whether low doses of Rapamycin, a drug most commonly used as an immunosuppressant following an organ transplant, can help to prevent Alzheimer's disease.

Featured Open Neuroscience Articles Psychology

·October 3, 2017·5 min read

Expectations Influence Effectiveness of SSRIs

Study reveals people are three times more likely to report SSRIs are effective for their depression and anxiety when given the correct information about the medication.

Featured Psychology

·August 15, 2017·4 min read

Will Ketamine Treat Your Depression? Check Your Activity Monitor

A new study reports depressed people who responded to ketamine found their activity increased during earlier parts of the day. Researchers suggest clock gene machinery may be linked to the type of depression that responds to ketamine treatment.